Meckler Jeffrey A has filed 28 insider transactions across 2 companies since January 2024.
Most recent transaction: a disposition of 3033 shares of Indaptus Therapeutics, Inc. ($INDP) on February 11, 2026.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 11, 2026 | Indaptus Therapeutics, Inc. | $INDP | Meckler Jeffrey A | Co-Chief Executive Officer | D | Warrants (right to buy) | 3033 | $0.00 | 0.0000 | 1,641,920 | 100.00% | 0.18% |
| Feb. 11, 2026 | Indaptus Therapeutics, Inc. | $INDP | Meckler Jeffrey A | Co-Chief Executive Officer | A | Warrants (right to buy) | 1519 | $0.00 | 1,519.0000 | 1,641,920 | 9999.99% | 0.09% |
| Feb. 11, 2026 | Indaptus Therapeutics, Inc. | $INDP | Meckler Jeffrey A | Co-Chief Executive Officer | D | Warrants (right to buy) | 1519 | $0.00 | 0.0000 | 1,641,920 | 100.00% | 0.09% |
| Feb. 11, 2026 | Indaptus Therapeutics, Inc. | $INDP | Meckler Jeffrey A | Co-Chief Executive Officer | A | Warrants (right to buy) | 3033 | $0.00 | 3,033.0000 | 1,641,920 | 9999.99% | 0.18% |
| Feb. 11, 2026 | Indaptus Therapeutics, Inc. | $INDP | Meckler Jeffrey A | Co-Chief Executive Officer | A | Warrants (right to buy) | 12136 | $0.00 | 12,136.0000 | 1,641,920 | 9999.99% | 0.74% |
| Feb. 11, 2026 | Indaptus Therapeutics, Inc. | $INDP | Meckler Jeffrey A | Co-Chief Executive Officer | D | Warrants (right to buy) | 12136 | $0.00 | 0.0000 | 1,641,920 | 100.00% | 0.74% |
| Dec. 22, 2025 | Indaptus Therapeutics, Inc. | $INDP | Meckler Jeffrey A | Co-Chief Executive Officer | A | Common Stock | 216617 | $2.03 | 229,929.0000 | 1,641,920 | 1627.23% | 13.19% |
| July 27, 2025 | Indaptus Therapeutics, Inc. | $INDP | Meckler Jeffrey A | Chief Executive Officer | A | Common Stock Warrants | 12136 | $8.30 | 16,688.0000 | 604,963 | 266.61% | 2.01% |
| July 27, 2025 | Indaptus Therapeutics, Inc. | $INDP | Meckler Jeffrey A | Chief Executive Officer | A | Common Stock | 6068 | $8.30 | 13,312.0000 | 604,963 | 83.77% | 1.00% |
| May 15, 2025 | Travere Therapeutics, Inc. | $TVTX | Meckler Jeffrey A | Not found | A | Common Stock | 6500 | $0.00 | 87,500.0000 | 78,888,861 | 8.02% | 0.01% |
| May 15, 2025 | Travere Therapeutics, Inc. | $TVTX | Meckler Jeffrey A | Not found | A | Stock option (right to buy) | 19500 | $0.00 | 19,500.0000 | 78,888,861 | 9999.99% | 0.02% |
| April 10, 2025 | Indaptus Therapeutics, Inc. | $INDP | Meckler Jeffrey A | Chief Executive Officer | D | Stock Option (right to buy) | 3750 | $0.04 | 0.0000 | 12,013,901 | 100.00% | 0.03% |
| April 10, 2025 | Indaptus Therapeutics, Inc. | $INDP | Meckler Jeffrey A | Chief Executive Officer | D | sStock Option (right to buy) | 1500 | $0.04 | 0.0000 | 12,013,901 | 100.00% | 0.01% |
| April 10, 2025 | Indaptus Therapeutics, Inc. | $INDP | Meckler Jeffrey A | Chief Executive Officer | D | Stock Option (right to buy) | 1563 | $0.04 | 0.0000 | 12,013,901 | 100.00% | 0.01% |
| April 10, 2025 | Indaptus Therapeutics, Inc. | $INDP | Meckler Jeffrey A | Chief Executive Officer | D | Stock Option (right to buy) | 1250 | $0.04 | 0.0000 | 12,013,901 | 100.00% | 0.01% |
| April 10, 2025 | Indaptus Therapeutics, Inc. | $INDP | Meckler Jeffrey A | Chief Executive Officer | D | Stock Option (right to buy) | 813 | $0.04 | 0.0000 | 12,013,901 | 100.00% | 0.01% |
| April 10, 2025 | Indaptus Therapeutics, Inc. | $INDP | Meckler Jeffrey A | Chief Executive Officer | D | Stock Option (right to buy) | 4750 | $0.04 | 0.0000 | 12,013,901 | 100.00% | 0.04% |
| Nov. 25, 2024 | Indaptus Therapeutics, Inc. | $INDP | Meckler Jeffrey A | CEO and Director | A | Common stock | 42553 | $1.18 | 202,859.0000 | 8,401,047 | 26.54% | 0.51% |
| Nov. 25, 2024 | Indaptus Therapeutics, Inc. | $INDP | Meckler Jeffrey A | CEO and Director | A | Common Stock Warrants | 42553 | $1.18 | 42,553.0000 | 8,401,047 | 9999.99% | 0.51% |
| Oct. 9, 2024 | Indaptus Therapeutics, Inc. | $INDP | Meckler Jeffrey A | CEO and Director | A | Stock Option (Right to Buy) | 75000 | $0.00 | 75,000.0000 | 8,401,047 | 9999.99% | 0.89% |
| Sept. 30, 2024 | Travere Therapeutics, Inc. | $TVTX | Meckler Jeffrey A | Not found | M | Common Stock | 40000 | $10.48 | 121,000.0000 | 74,267,418 | 49.38% | 0.05% |
| Sept. 30, 2024 | Travere Therapeutics, Inc. | $TVTX | Meckler Jeffrey A | Not found | M | Stock option (right to buy) | 40000 | $0.00 | 0.0000 | 74,267,418 | 0.00% | 0.05% |
| Sept. 30, 2024 | Travere Therapeutics, Inc. | $TVTX | Meckler Jeffrey A | Not found | S | Common Stock | 40000 | $14.06 | 81,000.0000 | 74,267,418 | 33.06% | 0.05% |
| Aug. 8, 2024 | Indaptus Therapeutics, Inc. | $INDP | Meckler Jeffrey A | CEO and Director | A | Common stock | 84932 | $1.83 | 160,306.0000 | 8,401,047 | 112.68% | 1.01% |
| Aug. 8, 2024 | Indaptus Therapeutics, Inc. | $INDP | Meckler Jeffrey A | CEO and Director | A | Common Stock Warrants | 84932 | $1.83 | 84,932.0000 | 8,401,047 | 9999.99% | 1.01% |
| May 8, 2024 | Travere Therapeutics, Inc. | $TVTX | Meckler Jeffrey A | Not found | A | Stock option (right to buy) | 19500 | $0.00 | 19,500.0000 | 74,267,418 | 9999.99% | 0.03% |
| May 8, 2024 | Travere Therapeutics, Inc. | $TVTX | Meckler Jeffrey A | Not found | A | Common Stock | 6500 | $0.00 | 81,000.0000 | 74,267,418 | 8.72% | 0.01% |
| Jan. 22, 2024 | Indaptus Therapeutics, Inc. | $INDP | Meckler Jeffrey A | CEO and Director | A | Stock Option (Right to Buy) | 100000 | $0.00 | 100,000.0000 | 8,401,047 | 9999.99% | 1.19% |